Loxo's first commercial medicine: The drug, larotrectinib, will be sold under the brand name Vitrakvi and priced at $32,800 per month, in partnership with Bayer AG.......
Portable smart phone-sized device for monitoring for cancer survivors, scientists say.......
An approach that improves the quality of life of terminally ill patients ......